FIELD: medicine. SUBSTANCE: method involves cleaning and condensing by ultrafiltering extract through polysulfonic and fluoroplastic membranes impermeable for hyaluronidase and permeable for ballast substances of lower molecular mass. Membrane permeability coefficient is not less than 10 kD. EFFECT: simplified production process; enhanced effectiveness in treating cicatrices, contractures, wounds.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING A PHARMACEUTICAL SUBSTANCE OF HYALURONIDASE | 2018 |
|
RU2703108C1 |
HYALURONIDASE PREPARATION AND METHOD OF ITS PREPARATION | 2016 |
|
RU2671537C2 |
METHOD OF HYALURONIDASE PREPARATION | 0 |
|
SU1723122A1 |
METHOD OF PREPARING HYALURONIDASE | 1999 |
|
RU2159284C1 |
METHOD FOR MANUFACTURE OF LYDASA | 1991 |
|
RU2036649C1 |
METHOD OF HYALURONIDASE PREPARING | 1992 |
|
RU2068267C1 |
METHOD FOR RHONIDASE PREPARATION | 0 |
|
SU1666534A1 |
METHOD OF PRODUCING ENZYME PREPARATIONS | 0 |
|
SU1090407A1 |
METHOD OF PRODUCING HYALUNIDASE | 0 |
|
SU955932A1 |
PREPARATION FOR TREATMENT OF CONNECTIVE TISSUE PATHOLOGICAL STATE | 1997 |
|
RU2112542C1 |
Authors
Dates
1997-09-20—Published
1993-07-30—Filed